Chemistry: analytical and immunological testing – Involving immune complex formed in liquid phase
Reexamination Certificate
1993-07-23
2002-11-19
Nguyen, Bao-Thuy L. (Department: 1640)
Chemistry: analytical and immunological testing
Involving immune complex formed in liquid phase
C436S537000, C436S546000, C436S172000, C436S800000, C436S805000, C530S402000
Reexamination Certificate
active
06482655
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Technical Field
This invention relates generally to biological assays, and more specifically to assay reagents labeled with fluorescent materials which reagents can be “toggled” from an intramolecular dimer to a fluorescent monomer by antibody binding.
2. State of the Art
Most clinical assays (e.g., immunoassays, DNA probe assays) are heterogeneous and consist of at least two steps: the binding of an antigen to its antibody, followed by physical separation of the bound from free antigens. In some more sensitive assays (e.g., “ELISA” or “EIA”) multiple steps are required. Homogeneous immunoassays, on the other hand, can distinguish between bound antigens and free ones without the need of additional separation steps. They are simple, rapid, yet more precise, more cost effective, and have the potential for total automation. For these reasons, separation-free assays are preferred in many applications such as biosensors, bioprobes and other automated instrumentation. J. P. Gosling,
Clin. Chem.,
36:1408-1427 (1990), D. W. Chan and M. T. Perlstein, Eds.,
Immunoassay. A Practical Guide
(Academic Press, New York, 1987), and E. F. Ullman and P. L. Khanna,
Methods in Enzymology,
74:28-60 (1981).
However, because of various technical complications homogeneous systems have been difficult to obtain, with the exception of a few assays suitable only for small molecules. J. F. Burd et al.,
Clin. Chem.,
23:1402-1408 (1977), M. E. Jolley et al.,
Clin. Chem.,
27:1190-1197 (1981), and D. L. Morris et al.,
Anal. Chem.,
53:658-665 (1981).
It would be an improvement in the art to develop and characterize new fluorogenic tracer antigens that can be used as “reporter molecules” for the binding event without the need of separation steps and the labeling of antibodies. The development of such tracers could greatly facilitate the automation of a large array of clinical assays, especially of high molecular weight antigens. It would help reduce the operational time and cost, and make such assays more readily accessible to doctors and patients. Also, such tracers would be extremely useful for rapidly screening large numbers of recombinant antibodies generated with genetic engineering techniques, such as those described in C. F. Barbas et al.,
Proc. Natl. Acad. Sci. USA
89:4457-4461 (1992), R. A. Lerner et al.,
Science
258:1313-1314 (1992), and Marks et al.
J. Biol. Chem.
267:16007-16010 (1992).
DISCLOSURE OF THE INVENTION
The invention includes a fluorogenic tracer antigen that obviates the need for separation steps or the labeling of antibodies in the performance of an assay. The tracer is a short antigen-mimicking peptide labeled with both a fluorescent energy transfer donor and fluorescent energy transfer acceptor molecules. When free in solution, the tracer exhibits very low fluorescence due to intramolecular dye dimerization. After binding to an antibody of the native antigen, fluorescence is significantly enhanced as a result of the dissociation of intramolecular dimers brought about by conformational changes in the tracer peptide.
The invention thus includes an immunoassay procedure for detecting and quantifying unknown analyte antibody or analyte antigen in bulk solution, to a reagent for use in such an immunoassay procedure, and to a process for making such a reagent. The reagent which is used in the present procedure is a peptide epitope that is recognized by the antibody in bulk solution, the peptide epitope conjugated to a pair of fluorescent energy transfer dyes capable of moving between a stacked configuration to exhibit fluorescence quenching and a spaced (unstacked) configuration to exhibit fluorescence.
A procedure for using the previously described reagent in a homogeneous antibody assay includes: placing in bulk solution a conjugate of a peptide epitope for the unknown amount of analyte antibody, and a pair of fluorescent dyes. This reagent is capable of moving between a stacked configuration to exhibit fluorescent quenching and a more spaced configuration to exhibit fluorescence. Also placed into the bulk solution is the unknown antibody which will bind with the peptide epitope which is conjugated to the pair of dyes. When this binding event occurs, the configuration of the pair of dyes will be altered between an initial stacked configuration (when in solution) to an unstacked configuration, when the epitope is bonded to the antibody, with a concomitant increase in fluorescent energy in response to the binding.
It is also within the contemplation of the invention to design a homogenous antigen assay or a homogenous DNA probe assay.
The tracers have uses including homogenous detection of macromolecules (e.g. antibodies, antigens, and DNA) of clinical interest and rapid screening of recombinant antibodies.
REFERENCES:
patent: 4318981 (1982-03-01), Burd et al.
patent: 4975380 (1990-12-01), Hummelen et al.
patent: 5237515 (1993-08-01), Herron et al.
patent: 2223096 (1990-03-01), None
Jiskoot et al., “Preparation and Application of a Fluorescein-Labeled Peptide for Determining the Affinity Constant of a Monoclonal Antibody-Hapten Compex by Fluorescence Polarization”, Analytical Biochemistry 196, pp. 421-426, 1991.
Kranz et al., “Kinetics and Mechanism of Deuterium Oxide-induced Fluorescence Enhancement of Ligand Bound to Specific Heterogeneous and Homogeneous Antibodies”, The Journal of Biological vol. 256, No. 9, Issue of May 10, 4433-4438, 1961.
Ullman et al., “Fluorescent Excitation Transfer Immunoassay”, The Journal of Biological Chemistry, vol. 251, No. 14, Issue of Jul. 25, pp. 4172-4178, 1976.
Barnard et al., “Chemical Sensors Based on Controlled-Release Polymer Systems”, Science, vol. 25, pp. 927-929, Feb. 22, 1991.
Bates et al.. “Comparative Properties Of Monoclonal Antibodies Comprising A High-Affinity Anti-Fluorescyl Idiotype Family”, Molecular Immunology, vol. 22, No. 8, pp. 871-877, 1985.
Bird et al., “Single-Chain Antigen-Binding Proteins”, Science, vol. 242, pp. 423-426, Oct. 21, 1988.
Farkas et al., “Fluorescence properties of bichromophoric molecules”, Spectrochimica, vol. 48A, No. 1, pp. 95-99, 1992.
Haas et al., “Distribution of End-to-End Distances of Oligopeptides in Solution as Estimated by Energy Transfer”, Proc. Nat. Acad. Sci. USA, vol. 72, No. 5, pp. 1807-1811, May 1975.
Kranz et al., “Partical Elucidation Of An Anti-Hapten Repertoire In Balb/c Mice: Comparative Characterization Of Several Monoclonal Anti-Fluorescyl Antibodies”, Molecular Immunology, vol. 18, No. 10, pp. 889-898, 1981.
Stryer et al., “Energy Transfer: A Spectroscopic Ruler”, Biochemistry Proc. N.A.S., vol. 58, pp. 719-726, 1967.
Ullman et al., “Fluorescence Excitation Transfer Immunoassay (FETI)”, Methods In Enzymology, vol. 74, pp. 28-60, 1981.
Wei et al., “Characterization of Fluorescent Dyes for Optical Immunosensors Based on Fluorescence Energy Transfer”, Biosensor Design And Application, pp. 105-120, 1992.
Wenska G., “Bichromophoric Compounds As Chemical Models In The Study Of The Photochemistry Of Nucleic Acids”, Journal of Photochemistry and Photobiology, A: Chemistry, 49, pp. 167-185, 1989.
Herron James N.
Wei Ai-Ping
Nguyen Bao-Thuy L.
TraskBritt
University of Utah Research Foundation
LandOfFree
Immunoassay procedure utilizing fluorogenic tracer antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay procedure utilizing fluorogenic tracer antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay procedure utilizing fluorogenic tracer antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2991907